Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathophysiology of malignant hyperthermia.

H Ording1

  • 1Department of Anaesthesia, Helsingør Sygehus, Denmark.

Annales Francaises D'Anesthesie Et De Reanimation
|January 1, 1989
PubMed
Summary

Malignant hyperthermia (MH) is a genetic disorder affecting muscle calcium regulation. Susceptible individuals experience dangerous calcium increases, leading to hypermetabolism, rigidity, and fever, treatable with dantrolene.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phrenic nerve block for thoracic surgery - a reply.

Anaesthesia·2017
Same author

A randomised, controlled, double-blind trial of ultrasound-guided phrenic nerve block to prevent shoulder pain after thoracic surgery.

Anaesthesia·2016
Same author

Guidelines for withholding and withdrawing therapy in the ICU: impact on decision-making process and interdisciplinary collaboration.

Heart, lung and vessels·2013
Same author

Sleep disturbances in critically ill patients in ICU: how much do we know?

Acta anaesthesiologica Scandinavica·2012
Same author

Withholding or withdrawing therapy in Danish regional ICUs: frequency, patient characteristics and decision process.

Acta anaesthesiologica Scandinavica·2011
Same author

Efficacy of A-line AEP Monitor as a tool for predicting acceptable tracheal intubation conditions during sevoflurane anaesthesia.

British journal of anaesthesia·2005

Area of Science:

  • Pharmacogenetics
  • Skeletal Muscle Physiology
  • Cellular Homeostasis

Background:

  • Malignant hyperthermia (MH) is a pharmacogenetic disorder primarily affecting skeletal muscle.
  • It involves a disruption of calcium homeostasis within muscle cells.
  • Susceptibility leads to damaging intracellular calcium levels triggered by specific agents or conditions.

Purpose of the Study:

  • To elucidate the mechanisms underlying Malignant hyperthermia.
  • To understand the role of calcium-induced calcium release in MH pathogenesis.
  • To describe the clinical manifestations and potential treatments for MH.

Main Methods:

  • The abstract does not detail specific experimental methods.
  • It relies on existing knowledge of MH pathophysiology.
  • Discussion of cellular events and biochemical consequences.

Main Results:

  • MH involves an abnormally sensitive calcium-induced calcium release mechanism, creating a vicious cycle.
  • Elevated intracellular calcium triggers muscle contraction, hypermetabolism, rigidity, and fever.
  • Cellular energy depletion and membrane damage lead to the release of intracellular components and acidosis.
  • Acidosis and hyperkalemia precipitate sympathetic stimulation, tachycardia, hypertension, and arrhythmias.
  • Dantrolene is identified as a treatment that inhibits calcium release.

Conclusions:

  • Malignant hyperthermia is characterized by a critical imbalance in muscle cell calcium regulation.
  • The condition results in severe metabolic and physiological disturbances.
  • Early intervention with dantrolene can mitigate the effects of MH.

Related Experiment Videos